Fasken Martineau DuMoulin

Fasken Martineau DuMoulin offers a full-service practice for life sciences clients, with capabilities in product liability litigation, patent disputes, financial and corporate matters, and regulatory advice. For the firm's activity across practice areas, Fasken was shortlisted for the Canadian Life Cycle Firm of the Year award by LMG Life Sciences.

Peter Pliszka is co-leader of the life sciences industry group, and one of leading attorneys in Canada for product liability litigation. He is currently acting for Sandoz in class action matters related to slow-release opioid pharmaceutical products. The firm was awarded Canadian Product Liability Firm of the Year in 2019.

Also co-leading the life sciences group is Sylvie Bourdeau, who is one of the firm's top advisors for all matters financial and corporate. Her specialties include mergers and acquisitions, commercial agreements, joint ventures and licensing. She recently assisted pharmaceutical client Cambrex in its acquisition of Halo Pharma. Bourdeau was shortlisted for Canadian Financial & Corporate Attorney of the Year.

For intellectual property, Julie Desrosiers is leader of the group with significant experience in life sciences patent litigation. "She is very good in pharma," a peer says, while another adds: "She wins a lot of cases." Desrosiers recently acted for Janssen in a high-profile patent suit related to the drug Remicade.

Indrid VanderElst continues to be an authority on IP and regulatory matters. She currently advises a number of life sciences clients, including a biomedical client on device development matters. VanderElst was shortlisted for the Canadian Regulatory Attorney of the Year award in 2019.